TapewireFind a company

person · Reporting owner

Baird Melissa

Disclosed activity across 1 company

Tapewire entity
79881
SEC CIK
0001837815

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Chief Operating OfficerMay 12, 2025May 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date May 12, 2025 · Filed May 13, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect805,083 Ending reported balance After 2025-05-12 transaction · row 5
5 source rows · reconciled sequence

Row 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13Direct693,795 Reported balance After 2025-05-12 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Filing footnotes · ownership attribution and instrument terms

F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2024 Filed Sep 5, 2024 18:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 11,749 $0.40 $4,699.60
Disclosure

SEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 597,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 18:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 11,884 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · derivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 484,176

Underlying: Class A Common Stock · 11,884 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 18:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 5,035 $14.49 $72,957.15
Disclosure

SEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.335 - $14.665. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 18:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,849 $14.49 $99,268.04
Disclosure

SEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 590,835

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.33 - $14.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 18:37 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 11,884 $0.40 $4,753.60
Disclosure

SEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 597,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
August 07, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,649 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 11

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 496,060

Underlying: Class A Common Stock · 16,649 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
August 07, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 16,649 $16.22 $269,998.50
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.89-$16.57. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 07, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 16,649 $0.40 $6,659.60
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 602,449

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,784 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 512,709

Underlying: Class A Common Stock · 16,784 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,260 $17.37 $126,117.09
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.21 - $17.74. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,524 $16.71 $159,190.80
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 593,060

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.09-$17.08. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 16,784 $0.40 $6,713.60
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 602,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 16,784 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 529,493

Underlying: Class A Common Stock · 16,784 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 10,351 $17.71 $183,327.60
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.26-$18.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,433 $16.82 $108,174.75
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 596,151

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.22-$17.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 05, 2024 Filed Aug 7, 2024 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 16,784 $0.40 $6,713.60
Disclosure

SEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 602,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
July 09, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,625 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 546,277

Underlying: Class A Common Stock · 17,625 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 09, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,625 $20.42 $359,886.64
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.92 - $20.695. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 09, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,625 $0.40 $7,050.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 603,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,625 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 563,902

Underlying: Class A Common Stock · 17,625 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,625 $20.90 $368,380.13
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.48 - $21.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 08, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,625 $0.40 $7,050.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 603,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
July 05, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,625 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 581,527

Underlying: Class A Common Stock · 17,625 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
July 05, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 17,625 $20.51 $361,561.01
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 585,800

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.05 - $20.745. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 05, 2024 Filed Jul 9, 2024 18:22 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,625 $0.40 $7,050.00
Disclosure

SEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 603,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 26,133 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,008

Underlying: Class A Common Stock · 26,133 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,222 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,665

Underlying: Class A Common Stock · 1,222 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,626 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,877

Underlying: Class A Common Stock · 1,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 8,295 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,886

Underlying: Class A Common Stock · 8,295 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 49 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146

Underlying: Class A Common Stock · 49 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 811 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,435

Underlying: Class A Common Stock · 811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,713 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,988

Underlying: Class A Common Stock · 18,713 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 16,297 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,270

Underlying: Class A Common Stock · 16,297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 28,778 $23.75 $683,477.50
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 585,800

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 17:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 73,146 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 614,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
June 05, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,625 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 12

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 599,152

Underlying: Class A Common Stock · 17,625 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
June 05, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,562 $21.66 $77,144.02
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 541,432

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.595 - $21.715. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 05, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 14,063 $21.25 $298,833.12
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 544,994

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.60 - $21.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 05, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,625 $0.40 $7,050.00
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 559,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 17,625 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 11

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 616,777

Underlying: Class A Common Stock · 17,625 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 8,332 $20.11 $167,590.68
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 541,432

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.50 - $20.49. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,293 $20.69 $192,269.38
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 549,764

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.495 - $20.855. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 17,625 $0.40 $7,050.00
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 559,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 70,506 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 634,402

Underlying: Class A Common Stock · 70,506 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,100 $20.86 $127,219.77
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 541,432

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.70 - $21.14. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 64,406 $20.32 $1,308,729.92
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 547,532

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.715 - $20.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 18:46 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 70,506 $0.40 $28,202.40
Disclosure

SEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 611,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F2 · balance_after: Includes 2,500 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.

Read SEC document
May 03, 2024 Filed May 3, 2024 18:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 11,750 $0.00 Strike: $0.40 $0.00
Disclosure

SEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · derivative · entry 14

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 704,908

Underlying: Class A Common Stock · 11,750 shares

Expires 2028-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.

Read SEC document
May 03, 2024 Filed May 3, 2024 18:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 700 $12.29 $8,599.50
Disclosure

SEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 11

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 538,932

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.24 - $12.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 03, 2024 Filed May 3, 2024 18:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,014 $11.57 $69,576.57
Disclosure

SEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 10

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 539,632

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.21 - $12.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.